biotech · KLRS
Kalaris Therapeutics
Kalaris Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
BERKELEY HEIGHTS, NJ, USA HQ
Public company Type
KLRS · NYSE Ticker
Company details
- Status
- Public
- HQ
- BERKELEY HEIGHTS, NJ, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 0
Kalaris Therapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Kalaris Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.